Changzheng Wang

5.1k total citations · 2 hit papers
94 papers, 3.2k citations indexed

About

Changzheng Wang is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Changzheng Wang has authored 94 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 38 papers in Physiology and 15 papers in Molecular Biology. Recurrent topics in Changzheng Wang's work include Asthma and respiratory diseases (35 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers) and Respiratory and Cough-Related Research (19 papers). Changzheng Wang is often cited by papers focused on Asthma and respiratory diseases (35 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers) and Respiratory and Cough-Related Research (19 papers). Changzheng Wang collaborates with scholars based in China, United States and Switzerland. Changzheng Wang's co-authors include Lydia Aguilar‐Bryan, Tohru Gonoi, John P. Clement, Nobuya Inagaki, Joseph Bryan, Nanshan Zhong, Jian Kang, Wan-zhen Yao, Ping Chen and Jiachun Lü and has published in prestigious journals such as Neuron, PLoS ONE and Biomaterials.

In The Last Decade

Changzheng Wang

86 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Family of Sulfonylurea Receptors Determines the Pharmacological Properties of ATP-Sensitive K+ Channels

1996 818 citations Changzheng Wang et al. profile →
Prevalence of Chronic Obstructive Pulmonary Disease in China

2007 558 citations Nanshan Zhong, Chen Wang et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Changzheng Wang China	24	1.2k	934	734	651	300	94	3.2k
Paola Giordano Italy	38	612 0.5×	520 0.6×	770 1.0×	278 0.4×	328 1.1×	286	5.3k
Grant W. Cannon United States	41	699 0.6×	501 0.5×	592 0.8×	679 1.0×	313 1.0×	200	6.2k
Manoj M. Lalu Canada	36	614 0.5×	450 0.5×	1.1k 1.5×	295 0.5×	705 2.4×	172	5.0k
Antonio Biondi Italy	37	533 0.4×	449 0.5×	951 1.3×	288 0.4×	346 1.2×	148	4.2k
Jingxia Liu United States	35	806 0.7×	462 0.5×	488 0.7×	184 0.3×	198 0.7×	231	4.1k
Xue Li China	38	387 0.3×	660 0.7×	1.5k 2.1×	600 0.9×	293 1.0×	209	5.4k
Tristan Grogan United States	34	994 0.8×	276 0.3×	897 1.2×	156 0.2×	451 1.5×	228	4.6k
David Burns United States	36	611 0.5×	1.4k 1.5×	1.2k 1.6×	337 0.5×	192 0.6×	121	4.9k
Dimitriοs Schizas Greece	32	1.2k 1.0×	291 0.3×	929 1.3×	262 0.4×	267 0.9×	349	4.7k
Huan Wang China	32	407 0.3×	373 0.4×	1.3k 1.8×	152 0.2×	283 0.9×	253	4.0k

Countries citing papers authored by Changzheng Wang

Since Specialization

Citations

This map shows the geographic impact of Changzheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changzheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changzheng Wang more than expected).

Fields of papers citing papers by Changzheng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changzheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changzheng Wang. The network helps show where Changzheng Wang may publish in the future.

Co-authorship network of co-authors of Changzheng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Changzheng Wang. A scholar is included among the top collaborators of Changzheng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changzheng Wang. Changzheng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Xiaoling, et al.. (2025). First-line combination therapy of immunotherapy plus anti-angiogenic drug for thoracic SMARCA4-deficient undifferentiated tumors in AIDS: a case report and review of the literature. Frontiers in Immunology. 15. 1473578–1473578.

Li, Jing, Changzheng Wang, Chuntao Liu, et al.. (2020). Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study. World Allergy Organization Journal. 13(12). 100469–100469. 2 indexed citations

Lin, Jiangtao, Xin Zhou, Changzheng Wang, et al.. (2018). Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines. Expert Review of Respiratory Medicine. 12(3). 191–202. 10 indexed citations

Lin, Jiangtao, Dong Yang, Mao Huang, et al.. (2018). Chinese expert consensus on diagnosis and management of severe asthma. Journal of Thoracic Disease. 10(12). 7020–7044. 9 indexed citations

Lai, Kefang, Huahao Shen, Xin Zhou, et al.. (2018). Clinical Practice Guidelines for Diagnosis and Management of Cough—Chinese Thoracic Society (CTS) Asthma Consortium. Journal of Thoracic Disease. 10(11). 6314–6351. 76 indexed citations

Gao, Jie, Kefang Lai, Xin Zhou, et al.. (2018). The characteristic of asthma control among nasal diseases population: Results from a cross-sectional study. PLoS ONE. 13(2). e0191543–e0191543. 10 indexed citations

Zhang, Mingzhou, Dehui Qian, Jiancheng Xu, et al.. (2017). Statins may be beneficial for patients with pulmonary hypertension secondary to lung diseases. Journal of Thoracic Disease. 9(8). 2437–2446. 8 indexed citations

Zheng, Danyang, et al.. (2016). Based on two element neighborhood search quantum genetic algorithm to solve the vehicle scheduling problem. 49. 2147–2150. 3 indexed citations

Ma, Qianli, Xiangdong Zhou, Ying Huang, et al.. (2016). Self‐reported reasons for treatment non‐adherence in Chinese asthma patients: A 24‐week prospective telephone follow‐up study. The Clinical Respiratory Journal. 12(1). 262–268. 10 indexed citations

10.

Zhong, Nanshan, Jinping Zheng, Kefang Lai, et al.. (2016). Uncontrolled asthma and its risk factors in adult Chinese asthma patients. Therapeutic Advances in Respiratory Disease. 10(6). 507–517. 29 indexed citations

11.

Qian, Hang, Changzheng Wang, Binfeng He, et al.. (2015). Regulation of vascular smooth muscle cell autophagy by DNA nanotube-conjugated mTOR siRNA. Biomaterials. 67. 137–150. 39 indexed citations

12.

Zhong, Nanshan, Changzheng Wang, Xiangdong Zhou, et al.. (2014). Late-breaking abstract: Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol/fluticasone combination (SFC) in patients with COPD: The LANTERN study. European Respiratory Journal. 44(Suppl 58). P2815–P2815. 8 indexed citations

13.

Zhang, Qiao, et al.. (2014). NAT2 slow acetylation genotypes contribute to asthma risk among Caucasians: evidence from 946 cases and 1,091 controls. Molecular Biology Reports. 41(3). 1849–1855. 5 indexed citations

14.

Huang, Yi, et al.. (2013). Effect of OVA activated tolerogenic mouse bone marrow dendritic cells on the production of IL-17 in vitro. European Respiratory Journal. 42(Suppl 57). P1569–P1569.

15.

Ma, Qianli, et al.. (2013). What are reasons for non-adherence in patients with asthma? A 24 weeks prospective telephone follow-up research. European Respiratory Journal. 42(Suppl 57). P963–P963. 1 indexed citations

16.

Zhou, Junhao, Hong Chen, Rui Li, et al.. (2013). [Respiratory physicians' knowledge, attitude and practice of tobacco control and their smoking status in the city of Chongqing].. PubMed. 36(4). 283–7. 3 indexed citations

17.

Cheng, Xiaoming, et al.. (2011). Re-survey on current status of treatment and control in asthmatic outpatients. Chinese Journal of Asthma. 31(11). 810–813. 1 indexed citations

18.

Zhang, Qiao, Qianli Ma, Qi Li, Wei Yao, & Changzheng Wang. (2010). Enhanced protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by oral multiantigen DNA vaccines delivered in attenuated Salmonella typhimurium. Molecular Biology Reports. 38(2). 1209–1217. 13 indexed citations

19.

Zhong, Nanshan, Chen Wang, Wan-zhen Yao, et al.. (2007). Prevalence of Chronic Obstructive Pulmonary Disease in China. American Journal of Respiratory and Critical Care Medicine. 176(8). 753–760. 558 indexed citations breakdown →

20.

Zhou, Xin, Fengming Ding, Jiangtao Lin, et al.. (2007). Validity of Asthma Control Test in Chinese patients. Chinese Medical Journal. 120(12). 1037–1041. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact